Page 3«..2345..1020..»

Faith groups reckon with AI and what it means to be truly human – Worcester Telegram

On a recent Sunday at the Queen Anne Lutheran Church basement, parishioners sat transfixed as the Rev. Dr. Ted Peters discussed an unusual topic for an afternoon assembly: "Can technology enhance the image of God?"

Peters' discussion focused on a relatively new philosophical movement. Its followers believe humans will transcend their physical and mental limitations with wearable and implantable devices.

The movement, called transhumanism, claims that in the future, humans will be smarter and stronger and may even overcome aging and death through developments in fields such as biotechnology and artificial intelligence (AI).

"What does it mean to be truly human?" Peters asked in a voice that boomed throughout the church basement, in a city that boasts one of the world's largest tech hubs. The visiting reverend urged the 30 congregants in attendance to consider the question during a time when "being human sounds optional to some people."

"It's sad; it makes me feel a lot of grief," a congregant said, shaking her head in disappointment.

Organized religions have long served as an outlet for humans to explore existential questions about their place in the universe, the nature of consciousness and free will. But as AI blurs the lines between the digital and physical worlds, fundamental beliefs about the essence of humanity are now called into question.

While public discourse around advanced technologies has mostly focused on changes in the workforce and surveillance, religious followers say the deeper implications of AI could be soul-shifting.

It doesn't surprise James Wellman, a University of Washington professor and chair of the Comparative Religion Program, that people of faith are interested in AI. Religious observers place their faith in an invisible agent known as God, whom they perceive as benevolent and helpful in their lives. The use of technology evokes a similar phenomenon, such as Apple's voice assistant Siri, who listens and responds to them.

"That sounds an awful lot like what people do when they think about religion," Wellman said.

CONFRONTING AI AND FAITH

When Dr. Daniel Peterson became the pastor of the Queen Anne Lutheran Church three years ago, he hoped to explore issues meaningful both to his congregants and to secular people.

Peterson's fascination with AI, as a lifelong science-fiction fan, belies skepticism in the ubiquity of technology: He's opted out of Amazon's voice assistant Alexa in his house and said he gets nervous about cameras on cellphones and computers.

He became interested in looking at AI from a "spiritual dimension" after writing an article last year about the depiction of technologies such as droids in "Star Wars" films. In Peterson's eyes, artificially intelligent machines in the films are equipped with a sense of mission that enables them to think and act like humans without needing to be preprogrammed.

His examination of AI yielded more questions than answers: "What kind of bias or brokenness are we importing in the artificial intelligence we're designing?" Peterson pondered. If AI developed consciousness, "what sort of philosophical and theological concerns does that raise?"

Peterson invited his church and surrounding community to explore these questions and more in the three-part forum called "Will AI Destroy Us?," which kicked off with a conversation held by Carissa Schoenick from the Seattle-based Allen Institute for Artificial Intelligence, followed by Peters' discussion on transhumanism, and concluded with Peterson's talk on his own research around AI in science-fiction films.

Held from late September to early October, the series sought to fill what Peterson called a silence among faith leaders about the rise of AI. Peterson and other religious observers are now eager to take part in a new creation story of sorts: Local initiatives held in places of worship and educational institutions are positioning Seattle as a testing ground for the intersection of AI and religion.

The discussion on transhumanism drew members of the community unaffiliated with the church, including David Brenner, the board chair of Seattle-based organization AI and Faith. The consortium membership spans across belief systems and academic institutions in an effort to bring major religions into the discussion around the ethics of AI, and how to create machines that evoke "human flourishing and avoids unnecessary, destructive problems," Brenner said in an interview at the church. As Brenner spoke, a few congregants remained in the basement to fervently chat about the symposium.

"The questions that are being presented by AI are fundamental life questions that have now become business [ones]," said Brenner, a retired lawyer. Values including human dignity, privacy, free will, equality and freedom are called into question through the development of machines.

"Should robots ever have rights, or is it like giving your refrigerator rights even if they can function just like us?" Brenner said.

AI, RELIGION AND THE WORLD

Religious leaders around the world are starting to weigh in. Last April, The Ethics & Religious Liberty Commission_the public-policy section of the Southern Baptist Convention published a set of guidelines on AI adoption that affirms the dominion of humans and encourages the minimization of human biases in technology. It discourages the creation of machines that take over jobs, relegating humans to "a life of leisure" devoid of work, wrote the authors.

In a speech to a Vatican conference in September, Pope Francis echoed the guidelines' sentiment by urging tech companies and diplomats to deploy AI in an ethical manner that ensures machines don't replace human workers. "If mankind's so-called technological progress were to become an enemy of the common good, this would lead to ... a form of barbarism dictated by the law of the strongest," he said, according to The Associated Press.

On the other hand, some faith perspectives have cropped up in recent years that hold AI at the center of their value systems. Former Google and Uber engineer Anthony Levandowski formed Way of the Future church in 2017 with the aim of creating a peaceful transition into an imminent world where machines surpass human capabilities. The church's website argues that human rights should be extended to machines, and that we should clear the path for technology to "take charge" as it grows in intelligence.

"We believe it may be important for machines to see who is friendly to their cause and who is not," the website warns.

But Yasmin Ali, a practicing Muslim and AI and Faith member, has seen AI used as a tool for good and bad. While Ali believes technology can make people's lives easier, she has also seen news reports and heard stories from her community about such tools being used to profile members of marginalized communities. China, for instance, has used facial-recognition technology to surveil Uighur Muslim minorities in the western region, according to a recent New York Times investigation.

"I think we need to get more diversity with the developers who provide AI, so they can get diverse thoughts and ideas into the software," Ali said. The Bellevue-based company she founded called Skillspire strives to do just that by training diverse workers in tech courses such as coding and cybersecurity.

"We have to make sure that those values of being human goes into what we're building," Ali said. "It's like teaching kids you have to be polite, disciplined."

Back at Queen Anne Lutheran, congregants expressed hope that the conversation would get the group closer to understanding and making peace with changes in society, just as churches have done for hundreds of years.

Bainbridge Island resident Monika Aring believes the rise of AI calls for an ongoing inquiry at faith-based places of worship on the role of such technologies. She shared the dismay she felt when her friend, a pastor of another congregation, said the church has largely become irrelevant.

"It mustn't be. This is the time for us to have these conversations," she said. "I think we need some kind of moral compass," one that ensures humans and the Earth continue to thrive amid the advancement of AI.

Here is the original post:
Faith groups reckon with AI and what it means to be truly human - Worcester Telegram

Recommendation and review posted by Alexandra Lee Anderson

Read the Rest...

Pomerantz Law Firm Announces the Filing of a Class Action against Lipocine Inc. and Certain Officers LPCN – GlobeNewswire

NEW YORK, Nov. 15, 2019 (GLOBE NEWSWIRE) -- Pomerantz LLP announce that a class action lawsuit has been filed against Lipocine Inc. (Lipocine or the Company) (NASDAQ:LPCN) and certain of its officers. The class action, filed in United States District Court, for the District of Utah, and docketed under 19-cv-00906, is on behalf of a class consisting of investors who purchased or otherwise acquired Lipocine securities between March 27, 2019, and November 8, 2019, both dates inclusive (the Class Period), seeking to recover damages caused by Defendants violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the Exchange Act) and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

If you are a shareholder who purchased Lipocine common shares within the Class Period, you have until January 14, 2020, to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at http://www.pomerantzlaw.com. To discuss this action, contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 9980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and number of shares purchased.

[Click here for information about joining the class action]

Lipocine is a specialty pharmaceutical company that focuses on the development of pharmaceutical products in the area of mens and womens health. The Companys primary development programs are based on oral delivery solutions for poorly bioavailable drugs. The Company has a portfolio of product candidates purportedly designed to produce pharmacokinetic characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability.

Lipocines lead product candidate is TLANDO (LPCN 1021), an oral testosterone replacement therapy. The Company has previously submitted New Drug Applications (NDA) for TLANDO twice and, both times, received Complete Response Letters (CRL) from the U.S. Food and Drug Administration (FDA) rejecting the NDAs. The Company received the first CRL in June 2016 and the second in May 2018.

On March 27, 2019, during pre-market hours, Lipocine issued a press release announcing new topline results from a study evaluating TLANDOs effects on blood pressure (one issue cited by the FDA in a prior CRL rejecting TLANDOs NDA), as well as the Companys intention to refile the NDA for TLANDO in the second quarter of 2019 (the March 2019 Press Release).

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Companys business, operational and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) the results from Lipocines clinical studies of TLANDO were insufficient to demonstrate the drugs efficacy; (ii) accordingly, Lipocines third NDA for TLANDO was highly likely to be found deficient by the FDA; and (iii) as a result, the Companys public statements were materially false and misleading at all relevant times.

On November 11, 2019, Lipocine issued a press release announcing receipt of a CRL from the FDA regarding its NDA for TLANDO. In the press release, Lipocine advised investors that the FDA had again rejected the NDA for TLANDOthis time because an efficacy trial had not met three of its secondary endpoints.

On this news, Lipocines stock price fell $1.93 per share, or 70.7%, to close at $0.80 per share on November 11, 2019.

The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See http://www.pomerantzlaw.com.

CONTACT:Robert S. WilloughbyPomerantz LLPrswilloughby@pomlaw.com

View post:
Pomerantz Law Firm Announces the Filing of a Class Action against Lipocine Inc. and Certain Officers LPCN - GlobeNewswire

Recommendation and review posted by Alexandra Lee Anderson

Read the Rest...

Testosterone Replacement Therapy Industry: Time to Invest in emerging Markets | Endo International, Pfizer, Novartis – News Description

AMA recently published a detailed study of over 180+ pages in its repository on Testosterone Replacement Therapy market covering interesting aspects of market with supporting development scenario till 2025. The study provides market size break-up by revenue and volume* for emerging countries and important business segments along with commentary on trending factors, growth drivers. Profiled players in study from the coverage used under bottom-up approach are AbbVie Inc. (United States), Endo International (Ireland), Eli Lilly and Company (United States), Pfizer (United States), Bayer (Germany), Actavis (Allergan) (United States), Novartis (Switzerland), Teva (Israel), Ferring Pharmaceuticals (Switzerland), Kyowa Kirin (Japan), Mylan (United States)

Next step one should take to boost sales? Track latest strategic steps and current scenario analysis of the market @ https://www.advancemarketanalytics.com/sample-report/46424-global-testosterone-replacement-therapy-market

Testosterone is responsible for the development of male sexual characteristics and this hormone formed by the testicles. Insufficient production of testosterone causes erectile dysfunction. Testosterone Replacement Therapy (TRT) is generally termed as hormone therapy for men, designed to counteract the effects of reduced activity in the gonads or hypogonadism. Hypogonadism in men is clinical syndrome, which results in the failure of the testes to produce physiological levels of testosterone. Erectile dysfunction arises due to reduce testosterone production to overcome this testosterone replacement therapy is used to improve the problem.

Market Segmentationby Type (Creams or Gels, Patches, Injections, Buccal Adhesives, Implants, Oral), Application (Hospitals, Clinics)

Make an enquiry before buying this Report @ https://www.advancemarketanalytics.com/enquiry-before-buy/46424-global-testosterone-replacement-therapy-market

Whats Trending in Market: Increasing awareness about testosterone substitute therapy

Growth Drivers: Increasing prevalence of hypogonadism in adult men

The need for having an offspring amongst men

Restraints: High possibility of side effects related to testosterone replacement therapy

View Detailed Table of Content @ https://www.advancemarketanalytics.com/reports/46424-global-testosterone-replacement-therapy-market

Country level Break-up includes:North America (United States, Canada and Mexico)Europe (Germany, France, United Kingdom, Spain, Italy, Netherlands, Switzerland, Nordic, Others)Asia-Pacific (Japan, China, Australia, India, Taiwan, South Korea, Middle East & Africa, Others)

Try a limited scope research document specific to Country or Regional matching your objective.

GET FULL COPY OF United States Testosterone Replacement Therapy market study @ USD 2000

And, Europe Testosterone Replacement Therapy market study @ USD 2500 Major Highlights of TOC:

Chapter One: Market Overview

Scope/Objective of the Study

Chapter Two: Executive Summary - Free of Cost

Chapter Three: Market Dynamics USD400

Market Drivers, Market Challenges, Market Trends

Chapter Four: Market Factor Analysis USD400

Supply/Value Chain Analysis, Porters Five Forces, PESTEL analysis, Market Entropy, Patent & Trademark Analysis, Market Development Scenario

Chapter Five and Seven: Global Testosterone Replacement Therapy, by Market Segmentation and Region (value, volume**) (2013-2024) USD2400

Global Testosterone Replacement Therapy

By Type (Creams or Gels, Patches, Injections, Buccal Adhesives, Implants, Oral)

By Application (Hospitals, Clinics)

Global Testosterone Replacement Therapy Region

North America (United States, Canada and Mexico)

Europe (Germany, France, United Kingdom, Spain, Italy, Netherlands, Switzerland, Nordic, Others)

Asia-Pacific (Japan, China, Australia, India, Taiwan, South Korea, Middle East & Africa, Others)

Chapter Six: Global Testosterone Replacement Therapy Manufacturers/Players Analysis USD1200

Competitive Landscape (Direct & Indirect Competitors), Market Share Analysis, Peer Group Analysis (2018), BCG Matrix, Company Profile, Downstream Buyers & Upstream Suppliers

..

Chapter Nine: Methodology/Research Approach, Data Source, Disclaimer

** If applicable

* Customized Section/Chapter wise Reports or Regional or Country wise Chapters are also available.

Buy this report @ https://www.advancemarketanalytics.com/buy-now?format=1&report=46424

Thanks for reading this article, you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

Contact Us: CRAIG FRANCIS (PR & Marketing Manager)[emailprotected]Ph: +1 (206) 317 1218

More here:
Testosterone Replacement Therapy Industry: Time to Invest in emerging Markets | Endo International, Pfizer, Novartis - News Description

Recommendation and review posted by Alexandra Lee Anderson

Read the Rest...

Vegetarianism | Definition of Vegetarianism by Merriam-Webster

The word vegetarian sprouted up in 1839. Fruitarian ("a person who lives on fruit") ripened by 1893. In 1944, vegetarians who consume no animal or dairy products began calling themselves vegans. Then, in 1993, those who eat fish but no other meat chose pesce, the Italian word for "fish," to create the designation pescatarian. In that same year, meatatarian was served up as a word for those whose diet largely includes meat; that word is rare, however, and is usually used in informal and humorous ways, making it the type of fare not included in our dictionaries. Another fairly recent dietary word is flexitarian, a person who follows a mostly vegetarian diet but occasionally eats meat or fish.

Excerpt from:
Vegetarianism | Definition of Vegetarianism by Merriam-Webster

Recommendation and review posted by Alexandra Lee Anderson

Read the Rest...

7 Types Of Vegetarian Diets, Explained By A Nutritionist – Women’s Health

Once upon a time, being a vegetarian was pretty black and white. You didnt eat meat, and that was that. These days, though, there seem to be 50 different shades of vegetarianism.

Theres more of an emphasis now on plant-based diets, and a lot of people want to explore different degrees of this, says Jessica Cording, RD, author of The Little Book of Game-Changers: 50 Healthy Habits For Managing Stress & Anxiety. Thats why were seeing more people interested in different types of vegetarian diets versus just being straight-up vegan or vegetarian.

The flexibility element is crucial. Its a key factor in how satisfied people are going to feel," Cording says. "We like to feel like we have a choice over what were eating. Taking a diet thats traditionally limited, like being a vegetarian, and making it your own can help you feel like youre still able to live a happy, balanced life while staying on an eating plan that supports your goals, Cording explains.

Of course, though, that can get confusing AF for everyone else.

Heres what you need to know about the most popular types of vegetarianism, so youre not left scrambling the next time a flexitarian, pescatarian, or any other type of vegetarian shows up for dinner.

Cording calls this version of vegetarianism the safest because it offers the most flexibility. A flexitarian diet is plant-based, meaning plant foods take center stage, but allows dieters to incorporate meat and other animal products here and there when the mood strikes.

Its great for somebody who is either new to the idea of eating a more plant-based diet or wants to reduce their intake of animal products without going all-in, Cording says. It can also be helpful if youre super busy and dont have a lot of time or resources to plan meals ahead of time, she says.

Pescatarians are people who choose to eat a mostly plant-based diet, but who also incorporate seafood as a source of protein (since they don't eat meat). Many pescatarians also eat dairy and eggs.

This tends to be good for somebody who wants to be primarily vegetarian but still loves fish or wants the nutritional benefits of fish, says Cording, who thinks pescatarianism makes covering your nutritional bases easier than traditional vegetarianism.

Pescatarians just need to be careful to limit their intake of mercury-heavy fish like swordfish and yellowfin tuna, Cording says. Instead, the FDA recommends opting for at least two to three servings of low-mercury seafood, like anchovies, shrimp, and salmon, per week.

One of the most popular (and traditional) forms of vegetarianism: lacto-ovo vegetarianism. Lacto-ovo vegetarians avoid meat, fish, and poultry, but still eat animal products like dairy and eggs.

This is right for someone who wants to be primarily vegetarian but not full-on vegan, Cording says, who finds lacto-ovo vegetarianism to be pretty approachable.

Still, if you notice that youre feeling tired or aren't satiated after your meals, take a closer look at your overall intake to make sure youre getting all the nutrients (like protein!) you need, says Cording.

One step beyond lacto-ovo vegetarians are lacto vegetarians, who eat a plant-based diet and dairy products, but avoid meat, seafood, and eggs. Yep, that means you can have plenty of milk, cheese, butter, and ice cream on this one.

Though many people do well on a lacto-vegetarian diet, Cording recommends keeping tabs on your dairy intake to make sure you dont OD on it. Otherwise, you might end up bloated and constipated.

While ovo vegetarians dont eat meat, seafood, or dairy products, they do eat eggs and products that contain eggs. Though not as popular as lacto-ovo vegetarian diet or even lacto vegetarian diets, this eating style does offer some flexibility, Cording says.

If you go this route, make sure your eggs are organic to lower your exposure to antibiotics and pesticides, she says.

While pollo means chicken in Spanish, pollo vegetarians typically incorporate multiple forms of poultry, like turkey and duck, into their otherwise plant-based diet. While pollo vegetarians avoid other forms of meat, they may or may not choose to incorporate seafood, eggs, and dairy into their diet.

Its really similar to a flexitarian diet, Cording says. Just do your best to eat organic chicken to reduce your exposure to antibiotics on this one.

Vegan

The least flexible of the vegetarian diets is veganism. The whole diet is plant-based, Cording says. Vegans don't eat any animal products, including meat, fish, poultry, dairy, and eggs.

Since vegan diets tend to be high in fiber and low in saturated fat, they can support heart health, says Cording. However, vegan diets are pretty restrictive and require more planning than other forms of vegetarianism. It can also be harder to feel satisfied, initially, especially if you're used to eating animal products, she says.

If you plan to go vegan, Cording recommends taking special care to ensure you get enough protein, iron, calcium, omega-3 fatty acids, and vitamin D.

More:
7 Types Of Vegetarian Diets, Explained By A Nutritionist - Women's Health

Recommendation and review posted by Alexandra Lee Anderson

Read the Rest...

India is Not a ‘Vegetarian Country’ Like the EAT-Lancet Report Would Have Us Believe – The Wire

Vegetarians, far less vegans, let us be frank, would not like to be compelled to eat meat. Yet the reverse compulsion is what lurks in the current proposals for a new planetary diet. Nowhere is this more visible than in India.

The subcontinent is often stereotyped by the West as a vegetarian utopia, where transcendental wisdom, longevity, and asceticism go hand in hand.

Earlier this year, the EAT-Lancet Commission released its global report on nutrition and called for a global shift to a more plant based diet: The scientific targets set by this Commission provide guidance for the necessary shift, which consists of increasing consumption of plant-based foods and substantially reducing consumption of animal source foods.

In the specific Indian context, the call to consume less animal foods has a special significance because it could become a tool to aggravate an already vexing political situation and stress already under nourished Indians.

Worryingly, the EAT report feeds into the false premise that traditional diets in countries like India include little red meat which might be consumed only on special occasions or as minor ingredients of mixed dishes.

In India, however, there is a vast difference between what people would wish to consume and what they have to consume because of innumerable barriers around caste, religion, culture, cost, geography, etc. Policy makers in India have traditionally pushed for a cereal heavy vegetarian diet on a meat-eating population as a way of providing cheapest sources of food.

The report says that legume consumption has traditionally been high in many cultures, such as India. Legumes are also expensive, provide low protein quality, are limited by poor digestibility and long cooking time. Often people consume watery legume gruel and that too, if it is available through the public distribution system, which is often erratic. They neither provide best quality proteins nor are they consumed in sufficient amounts.

Currently, food politics in India spearheads an aggressive new Hindu nationalism that has led to many of Indias meat eating minority communities being treated as inferior. Muslims, Christians, Dalits and Adivasis are overtly and covertly coerced into giving up their traditional foods to fit into a vegetarian Hindu identity.

Also read:Despite Nutrition Benefits, Most BJP States Keep Eggs out of Mid-Day Meals

The last two years have seen bitter political battles over provision of eggs, known to increase both taste and nutritional value, in the government supported school mid-day meal scheme.

While the Right to Food campaign, nutritionists, public health professionals and activists have argued in favour of eggs, religious organisations have labelled it a religious imposition, inspite of a majority of children accessing government schools being malnourished and from communities that traditionally eat eggs.

None of these concerns seem to have been appreciated by the EAT-Lancet Commissions representative Brent Loken, during the launch event at the Food Safety and Standards Authority of India (FSSAI) headquarters in New Delhi on April 4,2019. At one point during the launch, Loken states:

Where should we be getting our protein from? Is it from animal source foods or is it from plant source foods? This is where I think India has got such a great example. A lot of the protein sources come from plants. So I think India has an example that they can show the world.

Likewise, EATs co-founder, professor Johan Rockstrom has insisted:

India can show the world how traditional diets high in seeds, nuts, vegetables, whole grains and legumes can provide sustainable nutrition without wrecking the planet.

But how much of a model for the world is Indias vegetarianism then? In the Global Hunger Index 2019, the country ranks102ndout of117, whereas data from the National Family Health Survey indicate that only 10% of the infants between 623 months are adequately fed.

As a result, no less than 38% of the children under five years are stunted. About one on five women and men are underweight, with a similar proportion being either overweight or obese, especially in urban settings.

Anaemia affects almost 60% of the children aged 6-59 months, more than half of the women between 15-49 years, and almost one on four men in that same age group. Subclinical vitamin A deficiency in preschool children is 62% and is closely associated with malnutrition and poor protein consumption. Hardly a model to be followed.

Children holding plates wait in a queue to receive food at an orphanage run by a non-governmental organisation on World Hunger Day, in Chennai May 28, 2014.Photo: Reuters/Babu/Files

So when EAT-Lancets food campaign islaunched in India, run by billionaires but claiming to speak for the worlds poor, it risks sanctioning and rationalising caste-based impositions that poor Indians reel under. In short, it offers another whip to beat already vulnerable communities.

A diet directed at the affluent West fails to recognise that in low-income countries undernourished children are known to benefit from the consumption of milk and other animal source foods, improving anthropometric indices and cognitive functions, whilst reducing the prevalence of nutritional deficiencies as well as morbidity and mortality.

Or that, in India, bone fracture and shorter heights in India have been associated with lower milk consumption. Importantly, traditional livestock gets people through difficult seasons, prevents malnutrition in impoverished communities, and provides economic security.

Also read:India Ranks 102 Out of 117 Countries in Global Hunger Index

EAT-Lancet claimed its intention was to spark conversations among all Indian stakeholders. The conversation, however, was far from being sparked and the stakeholders were carefully narrowed down to yea-sayers.

Vocal critics of the food processing industry and food fortification strategies, such as the Right to Food campaign, have been left out of the debate along with the National Institute of Nutrition, the 100-year old government nutrition research body whose research points in favour of animal source foods.

But the most blatant omission may as well be the fact that Indias farmers were conspicuously absent.

The alacrity with which FSSAI is ready to promote and project the EAT-Lancet approach seems to subvert democratic consultation processes and to prefer instead the route of unilateral decision making, with the usual multinational businesses as their favourite bed-mates.

Could it be that critical voices are too much of a nuisance when it comes to endorsement of certain industrial agendas by the EAT foundation and its Indian backers? The manufacturing of a plant-based lifestyle is a highly lucrative one, with cheap materials such as pea protein extracts, starches, and plant oils at its base.

As a result, various business solutions have been worked out by such companies as Deloitte, in support of the Great Food Transformation and its associated partners of the World Business Council for Sustainable Development.

FSSAI has been embroiled in similar controversies with its scientific panel being populated with experts from the food and beverage industry. The organisation also promotes fortification of foods to the benefit of international firms in alliance with the events co-host, the Global Alliance for Improved Nutrition.

These schemes have been criticised, especially now that a Cochrane review has shown that fortification of rice makes little or no difference to addressing anaemia or vitamin A deficiency.

Rather than addressing chronic hunger and malnutrition through an improved access to wholesome and nutrient-dense foods, the government is thus opening the door for company-dependent solutions.

What is conveniently being ignored here are the environmental and economic cost of shifting tonnes of micronutrients from Western countries on a permanent basis, while at the same time destroying local food systems.

Dr. Sylvia Karpagam is a public health doctor and researcher working with the Right to Food and Right to Health campaigns in India.

Frdric Leroy is a professor of food science and technology, investigating the scientific and societal aspects of animal food products, writing in individual capacity.

Martin Cohen is a social scientist whose latest book I Think Therefore I Eat (2018) takes a philosophical and sociological look at food science and argues for a more holistic approach to food and health debates.

Continued here:
India is Not a 'Vegetarian Country' Like the EAT-Lancet Report Would Have Us Believe - The Wire

Recommendation and review posted by Alexandra Lee Anderson

Read the Rest...

Nanomedicine Market Segmented by Applications and Geography Trends, Growth and Forecasts 2026 – The Bay State Herald

A new market assessment report on the Nanomedicine market provides a comprehensive overview of the Nanomedicine industry for the forecast period 2019 2026. The analytical study is proposed to provide immense clarity on the market size, share and growth rate across different regions. The profound knowledge and extensive examination of the trends from the yesteryear and future aims at offering the stakeholders, product owners, and marketing personnel a competitive edge over others operating in the Agricultural Tires market for the forecast period, 2019 2026.

The study will also feature the key companies operating in the industry, their product/business portfolio, market share, financial status, regional share, segment revenue, SWOT analysis, key strategies including mergers & acquisitions, product developments, joint ventures & partnerships an expansions among others, and their latest news as well. The study will also provide a list of emerging players in the Nanomedicine market.

In this report, theglobal Nanomedicine marketis valued atUSD xx million in 2019and is expected to reachUSD xx millionby the end of2026, growing at aCAGR of xx.x%between 2019 and 2026.

Download FREE Sample Brochure (Customized Sample PDF File delivered as per your specific requirement) @https://www.reportsanddata.com/sample-enquiry-form/1048

The major manufacturers covered in this report:Arrowhead Pharmaceuticals Inc. AMAG Pharmaceuticals, Bio-Gate AG, Celgene Corporation and Johnson & Johnson. Johnson & Johnson

The study is a professional probe into the revenue generated and capacity estimates for the Nanomedicine market for the forecast period 2019 2026 empower the business owners to maintain a competitive edge over their rivals.

The research further examines and provides data on the market by type, application and geography interspersed with illustrations and other graphical representations. The market analysis not only determines the attractiveness of the industry but also the evolving challenges and opportunities and their association with the weaknesses and strengths of prominent market leaders.

Other factors taken into consideration when studying the industry include profitability, manufacturing capability, distribution channels and industry cost structure and major success factors.

The industry experts have left no stone unturned to identify the major factors influencing the development rate of the Nanomedicine industry including various opportunities and gaps. A thorough analysis of the micro markets with regards to the growth trends in each category makes the overall study interesting. When studying the micro markets the researchers also dig deep into their future prospect and contribution to the Nanomedicine industry.

Product Outlook (Revenue, USD Billion, 2018-2026)

Therapeutics

Regenerative Medicine

In-vitro diagnostics

In-vivo diagnostic

Vaccines

Drug Delivery System Outlook (Revenue, USD Billion, 2018-2026)

Nanobots

Nanoghosts

Nanoclusters

Nanobubbles

Exosomes

Injectable Nanoparticle Generator

Dendrimers

Liposomes

Carbon nanotube

Graphene

Others

Application Outlook (Revenue, USD Million, 2015-2026)

Oncology

Infectious diseases

Cardiology

Orthopedics

Others

!!! Limited Time DISCOUNT Available!!! Get Your Copy at Discounted [emailprotected]https://www.reportsanddata.com/discount-enquiry-form/1048

Key Research:

The main sources are industry experts from the global Nanomedicine industry, including management organizations, processing organizations, and analytical services providers that address the value chain of industry organizations. We interviewed all major sources to collect and certify qualitative and quantitative information and to determine future prospects. Through interviews in the industry experts industry, such as CEO, vice president, marketing director, technology and innovation director, founder and key executives of key core companies.

Secondary Research:

Secondary research studies critical information about the industrial value chain, core pool of people, and applications. We also helped market segmentation based on the industrys lowest level of industry, geographical markets and key developments in market and technology-driven core development.

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering:

United States

Europe

China

Japan

Southeast Asia

India

Incorporated with Info-graphics, charts, 75 tables and 105 figures, this 243-page research report NanomedicineMarket Size, Type Analysis, Application Analysis, End-Use Industry Analysis, Regional Outlook, Competitive Strategies And Forecasts, 2019 2026 is based on a complete research of the entire Global market and covering all its sub-segments through comprehensively thorough classifications. Insightful analysis and assessment are created from superior primary and secondary information sources with data and information derived from industry specialists across the value chain. The report provides historical market data for 2014-2018, base year estimates for 2018, and forecasts from 2019 to 2026.

Table of Contents:

Report Overview:It includes the objectives and scope of the study and gives highlights of key market segments and players covered. It also includes years considered for the research study.

Executive Summary:It covers industry trends with high focus on market use cases and top market trends, market size by regions, and global market size. It also covers market share and growth rate by regions.

Key Players:Here, the report concentrates on mergers and acquisitions, expansions, analysis of key players, establishment date of companies, and areas served, manufacturing base, and revenue of key players.

Breakdown by Product and Application:This section provides details about market size by product and application.

Regional Analysis:All of the regions and countries analyzed in the report are studied on the basis of market size by product and application, key players, and market forecast.

Profiles of International Players:Here, players are evaluated on the basis of their gross margin, price, sales, revenue, business, products, and other company details.

Market Dynamics:It includes supply chain analysis, analysis of regional marketing, challenges, opportunities, and drivers analyzed in the report.

Appendix:It includes details about research and methodology approach, research methodology, data sources, authors of the study, and a disclaimer.

For further information on this analysis, please visit @https://www.reportsanddata.com/report-detail/nanomedicine-market

Why Choose Reports and Data?

Request customized copy of Nanomedicine report

We are grateful to you for reading our report. If you wish to find more details of the report or want a customization, contact us. You can get a detailed information of the entire research here. If you have any special requirements, please let us know and we will offer you the report as you want.

Have Any Query? Ask Our Expert @https://www.reportsanddata.com/make-enquiry-form/1048

See the rest here:
Nanomedicine Market Segmented by Applications and Geography Trends, Growth and Forecasts 2026 - The Bay State Herald

Recommendation and review posted by Alexandra Lee Anderson

Read the Rest...

Nanotherapies for Rheumatoid Arthritis: Advantages, Challenges, and Future Direction – Rheumatology Advisor

Despite recent advances in the treatment of rheumatoid arthritis(RA) attributed to biologic medications, only a minority of patients achieve andmaintain disease remission without the need for continuous immunosuppressive therapy.1Complicating the treatment of RA further is the development of tolerance over timeor failure of patients to respond to currently available therapies.1Thus, the development of new treatment strategies for RA remains a priority.

Nanotherapies for RA have received increasing attention in the past decade because they offer several potential advantages compared with conventional systemic therapies.2 Nanocarriers are submicron transport particles designed to deliver the drug at the site of inflammation the synovium thereby maximizing its therapeutic effect and avoiding unwanted systemic adverse effects.1 This targeted drug delivery approach also has the potential to minimize the amount of drug required to control joint inflammation3 and increase local bioavailability by protecting it from degradation in the circulation.1

In essence, nanotechnology enables the redesign of alreadyeffective rheumatologic medications into nanoformulations that may confer greaterspecificity, longer therapeutic effect, and more amenable safety profile.4Nanoencapsulated nonsteroidal anti-inflammatory drugs (NSAIDs),5 liposomaland polymeric preparations of glucocorticoids,6 and nanosystems thatdirectly inhibit angiogenesis are just several examples of nanotherapies that havebeen tested in experimental models of inflammatory arthritis.7

Despite the promising findings observed in studies to date, further development and subsequent integration of nanotherapies in the management of RA remains hampered by the lack of efficacy and toxicity studies in humans. In an interview with Rheumatology Advisor, Christine Pham, MD, chief of the Division of Rheumatology at the Washington University School of Medicine in St Louis, discussed the advantages and challenges of applying nanotherapies in RA.

RheumatologyAdvisor: How can nanotechnology be applied in the treatment of RA?

ChristinePham, MD: Nanotechnology is a multidisciplinary approach aimed at the deliveryof therapeutic agents using submicron nanocarriers. In RA, the vessels at the siteof inflammation are leaky, allowing passage of these nanocarriers from the circulationto specific target sites in the joint environment.

RheumatologyAdvisor: Which RA drugs are suitable forthis approach?

DrPham: Many conventionalantirheumatic drugs such as methotrexate, glucocorticoids, and NSAIDs have beensuccessfully delivered by nanocarriers to mitigate inflammatory arthritis in experimentalmodels.

RheumatologyAdvisor: Whatare the main advantages of using nanotherapy/nanocarriers, as opposed to systemictherapy, in the treatment of RA?

DrPham: The mainadvantages are selective drug delivery to desired sites of action through passiveor active targeting, which can lead to increased local bioavailability and potentiallycan reduce unwanted off-target side effects. In addition, nanocarriers may increasethe solubility of certain drugs and protect therapeutics against degradation inthe circulation.

RheumatologyAdvisor: Howfar has the medical community gotten in developing (and testing) nanotherapies forRA? Which nanotherapies have shown the most promise?

DrPham: A numberof nanotherapeutics have been developed and tested in animal models of RA. Mosthave shown disease mitigation, however, none has so far made it to the clinic.

RheumatologyAdvisor: Whatneeds to happen before nanotherapies can get fully integrated into clinical practiceand treatment of patients with RA?

DrPham: Insufficientdata regarding long-term toxicity and optimal therapeutic efficacy have hamperedtheir integration into clinical practice. Anticytokine biologics have been verysuccessful, so nanotherapeutics need to show clearly that they have higher efficacyand lower toxicity for pharmaceutical companies to invest in their development forthe clinic.

Rheumatology Advisor: Are any other promising treatment strategies for RA currently under investigation?

DrPham: RNA interference(RNAi) has recently emerged as a specific way to silence gene expression. The invivo delivery of small interfering RNA (siRNA), however, remains a significant hurdle,given the short half-life of the molecule in the circulation. We have used a self-assemblingpeptide-based nanosystem that protects the siRNA from degradation when injectedintravenously and which has shown to mitigate experimental RA.8,9 siRNAworks by knocking down NFkappaB p65, asubunit of NF-kappa-B transcription complex which plays acentral role in inflammation in general and in RA in particular. This platform promisesto have real translational potential.

References

1. Pham CTN. Nanotherapeutic approaches for the treatment of rheumatoid arthritis. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2011;3(6):607-619.

2. Dolati S, Sadreddini S, Rostamzadek D, Ahmadi M, Jadidi-Niaragh F, Yousefi M. Utilization of nanoparticle technology in rheumatoid arthritis treatment. Biomed Pharmacother. 2016;80:30-41.

3. Rubinstein I, Weinberg GL. Nanomedicine for chronic non-infectious arthritis: the clinicians perspective. Nanomedicine. 2012;8(Suppl 1):S77-S82.

4. Henderson CS, Madison AC, Shah A. Size matters nanotechnology and therapeutics in rheumatology and immunology. Curr Rheumatol Rev. 2014;10(1):11-21.

5. Srinath P, Chary MG, Vyas SP, Diwan PV. Long-circulating liposomes of indomethacin in arthritic ratsa biodisposition study. Pharm Acta Helv. 2000;74:399-404.

6. Metselaar JM, Wauben MH, Wagenaar-Hilbers JP, Boerman OC, Storm G. Complete remission of experimental arthritis by joint targeting of glucocorticoids with long-circulating liposomes. Arthritis Rheum. 2003;48:2059-2066.

7. Koo OM, Rubinstein I, nyuksel H. Actively targeted low-dose camptothecin as a safe, long-acting, disease-modifying nanomedicine for rheumatoid arthritis. Pharm Res. 2011;28:776-787.

8. Zhou H-F, Yan H, Pan H, et al. Peptide-siRNA nanocomplexes targeting the NF-kB subunit p65 suppress nascent experimental arthritis. J Clin Invest. 2014;124:4363-4374.

9. Rai MF, Pan H, Yan H, Sandell L, Pham C, Wickline SA. Applications of RNA interference in the treatment of arthritis. Transl Res. 2019;214:1-16.

Follow this link:
Nanotherapies for Rheumatoid Arthritis: Advantages, Challenges, and Future Direction - Rheumatology Advisor

Recommendation and review posted by Alexandra Lee Anderson

Read the Rest...

Global Nanorobotics Market : Industry Analysis and Forecast (2018-2026) – Markets Gazette 24

Global Nanorobotics Marketwas valued at US$ 3.7 Bn in 2017 and is expected to reach US$ 9.2Bn by 2026, at a CAGR of 12.06%during a forecast period.Global Nanorobotics MarketDevelopments in nanotechnology coupled with demand for minimally aggressive procedures are expected to drive market growth over the forecast period. Nanobots possess likely in the medical sector for destroying cancerous cells at the genetic level. Increasing support for nanomedicine by many nations and the increasing geriatric population are factors which can augur market demand.

Utilization of nanobots in the ranostics can be beneficial for the market in the near future. A rise in miniaturization and demand for automation across various sectors are anticipated to fuel market growth. Training of new personnel to use nanobots can restrain market growth in the upcoming years.Nanomedicine application segment to grow at the highest CAGR during the forecast period. Nanorobotics is widely used in nanomedicine owning to its healthcare features. The large share of this application aspects to the large level of commercialization in the healthcare sector for drug delivery, in vivo imaging, biomaterial, in vitro diagnostic, active implants, and drug therapy.

North America region accounted for the largest share of 12.2%, in terms of value, of the nanorobotics market globally. Presence of many nanotechnology companies, well-developed healthcare infrastructure, and government initiatives to create patient awareness are factors driving the market. The U.S is anticipated to contribute to market revenue owing to the increase in cardiovascular diseases and the rising elderly populace.

REQUEST FOR FREE SAMPLE REPORT:https://www.maximizemarketresearch.com/request-sample/30888

Europe follows North America as the second biggest nanorobotics market. Presence of chronic diseases and the burgeoning population are factors expected to indicate the Europe nanobots market. Establishment of organizations to develop standards pertaining to nanotechnology can expand market growth. In 2018, DNA-Robotics, an organization including 12 European companies, has outlined steps to expedite production of nanobots on a large scale. These standards can help scale the market exponentially in the upcoming years.

A recent development in nanorobotics market: In March 2018, Thermo Fisher Scientific acquired Gatan, an exclusively owned subsidiary of Roper Technologies. Gatan is an electron microscopy solutions provider in the U.S, which accompaniments the Thermo Fisher Scientifics electron microscopy solutions business.In March 2017, Oxford Instruments (U.K) Asylum Research introduced its new SurfRider HQ-Series of high quality, budget-priced AFM probes, which are also existing in a model suitable for nanomechanical image mode.

The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding Global Nanorobotics Market dynamics, structure by identifying and analyzing the market segments and project the global market size. Further, the report also focuses on the competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTERs analysis, SWOT analysis to address the question of shareholders to prioritizing the efforts and investment in the near future to the emerging segment in the Global Nanorobotics Market.

DO INQUIRY BEFORE PURCHASING REPORT HERE:https://www.maximizemarketresearch.com/inquiry-before-buying/30888

Scope of the Global Nanorobotics Market

Global Nanorobotics Market, By Type

Nanomanipulatoro Electron Microscope (EM) Scanning Electron Microscope (SEM) Transmission Electron Microscope (TEM)o Scanning Probe Microscope (SPM) Atomic Force Microscopes (AFM) Scanning Tunneling Microscope (STM) Bio-Nanorobotics Magnetically Guided Bacteria-Based

Global Nanorobotics Market, By Application

Nanomedicine Biomedical Mechanical Others

Global Nanorobotics Market, By Region

North America Europe Asia Pacific Middle East and Africa South America

Key players operating in Global Nanorobotics Market:

Bruker JEOL Thermo Fisher Scientific Ginkgo Bioworks Oxford Instruments EV Group Imina Technologies Toronto Nano Instrumentation KlockeNanotechnik KleindiekNanotechnik Xidex Synthace Park Systems Smaract Nanonics Imaging

Key Innovators:

Novascan Technologies Angstrom Advanced Hummingbird Scientific NT-MDT Spectrum Instruments Witec

Browse Full Report with Facts and Figures of nanorobotics Market Report at:https://www.maximizemarketresearch.com/market-report/global-nanorobotics-market/30888/

MAJOR TOC OF THE REPORT

Chapter One: nanorobotics Market Overview

Chapter Two: Manufacturers Profiles

Chapter Three: Global nanorobotics Market Competition, by Players

Chapter Four: Global nanorobotics Market Size by Regions

Chapter Five: North America nanorobotics Revenue by Countries

Chapter Six: Europe nanorobotics Revenue by Countries

Chapter Seven: Asia-Pacific nanorobotics Revenue by Countries

Chapter Eight: South America nanorobotics Revenue by Countries

Chapter Nine: Middle East and Africa Revenue nanorobotics by Countries

Chapter Ten: Global nanorobotics Market Segment by Type

Chapter Eleven: Global nanorobotics Market Segment by Application

Chapter Twelve: Global nanorobotics Market Size Forecast (2019-2026)

About Us:

Maximize Market Research provides B2B and B2C market research on 20,000 high growth emerging technologies & opportunities in Chemical, Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

Contact info:

Name: Lumawant Godage

Organization: MAXIMIZE MARKET RESEARCH PVT. LTD.

Email: sales@maximizemarketresearch.com

Contact: +919607065656/ +919607195908

Website: http://www.maximizemarketresearch.com

See the rest here:
Global Nanorobotics Market : Industry Analysis and Forecast (2018-2026) - Markets Gazette 24

Recommendation and review posted by Alexandra Lee Anderson

Read the Rest...

Global Egg Phosphatidylcholine Market: What it got next? Find out with the latest research available at ‘The Market Reports’ – Market Research Writeup

Egg Phosphatidylcholine appear to regulate cholesterol absorption and inflammation. With an increase in old age population, the demand for egg phosphatidylcholine is expected to increase as it improves the functionality of liver thereby enhancing digestive system functioning resulting in relief to aged people.

Access Report Details at: https://www.themarketreports.com/report/global-egg-phosphatidylcholine-market-research-report

The global Egg Phosphatidylcholine market is valued at 14 million US$ in 2018 is expected to reach 22 million US$ by the end of 2025, growing at a CAGR of 5.9% during 2019-2025.

This report focuses on Egg Phosphatidylcholine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Egg Phosphatidylcholine market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.

Key companies profiled in Egg Phosphatidylcholine Market report are Nutrasal,Avanti Polar Lipids, Lipoid, Natural Factors, Kewpie, Nof, Jena Bioscience, Vitamin Research Productsand more in term of company basic information, Product Introduction, Application, Specification, Production, Revenue, Price and Gross Margin (2014-2019), etc.

Purchase this Premium Report at: https://www.themarketreports.com/report/buy-now/1418109

Table of Content

1 Egg Phosphatidylcholine Market Overview

2 Global Egg Phosphatidylcholine Market Competition by Manufacturers

3 Global Egg Phosphatidylcholine Production Market Share by Regions

4 Global Egg Phosphatidylcholine Consumption by Regions

5 Global Egg PhosphatidylcholineProduction, Revenue, Price Trend by Type

6 Global Egg Phosphatidylcholine Market Analysis by Applications

7 Company Profiles and Key Figures in Egg Phosphatidylcholine Business

8 Egg Phosphatidylcholine Manufacturing Cost Analysis

9 Marketing Channel, Distributors and Customers

10 Market Dynamics

11 Global Egg Phosphatidylcholine Market Forecast

12 Research Findings and Conclusion

13 Methodology and Data Source

See the original post here:
Global Egg Phosphatidylcholine Market: What it got next? Find out with the latest research available at 'The Market Reports' - Market Research Writeup

Recommendation and review posted by Alexandra Lee Anderson

Read the Rest...

Page 3«..2345..1020..»